Cargando…
Ruthenium(II) Polypyridyl Complexes as FRET Donors: Structure- and Sequence-Selective DNA-Binding and Anticancer Properties
[Image: see text] Ruthenium(II) polypyridyl complexes (RPCs) that emit from metal-to-ligand charge transfer (MLCT) states have been developed as DNA probes and are being examined as potential anticancer agents. Here, we report that MLCT-emissive RPCs that bind DNA undergo Förster resonance energy tr...
Autores principales: | Elgar, Christopher E., Yusoh, Nur Aininie, Tiley, Paul R., Kolozsvári, Natália, Bennett, Laura G., Gamble, Amelia, Péan, Emmanuel V., Davies, Matthew L., Staples, Christopher J., Ahmad, Haslina, Gill, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853847/ https://www.ncbi.nlm.nih.gov/pubmed/36607895 http://dx.doi.org/10.1021/jacs.2c11111 |
Ejemplares similares
-
Combining PARP Inhibition with Platinum, Ruthenium or Gold Complexes for Cancer Therapy
por: Yusoh, Nur Aininie, et al.
Publicado: (2020) -
Synergy of ruthenium metallo-intercalator, [Ru(dppz)(2)(PIP)](2+), with PARP inhibitor Olaparib in non-small cell lung cancer cells
por: Yusoh, Nur Aininie, et al.
Publicado: (2023) -
Discovery of
Ruthenium(II) Metallocompound and Olaparib
Synergy for Cancer Combination Therapy
por: Yusoh, Nur Aininie, et al.
Publicado: (2023) -
Synthesis and Optimization of Mesoporous Silica Nanoparticles for Ruthenium Polypyridyl Drug Delivery
por: Harun, Siti Norain, et al.
Publicado: (2021) -
A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
por: Gill, Martin R., et al.
Publicado: (2016)